BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 16690706)

  • 1. AMPK alterations in cardiac physiology and pathology: enemy or ally?
    Dyck JR; Lopaschuk GD
    J Physiol; 2006 Jul; 574(Pt 1):95-112. PubMed ID: 16690706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart.
    Hopkins TA; Dyck JR; Lopaschuk GD
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):207-12. PubMed ID: 12546686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP-activated protein kinase control of energy metabolism in the ischemic heart.
    Lopaschuk GD
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S29-35. PubMed ID: 18719595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual cardiac contractile effects of the alpha2-AMPK deletion in low-flow ischemia and reperfusion.
    Carvajal K; Zarrinpashneh E; Szarszoi O; Joubert F; Athea Y; Mateo P; Gillet B; Vaulont S; Viollet B; Bigard X; Bertrand L; Ventura-Clapier R; Hoerter JA
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H3136-47. PubMed ID: 17337600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart.
    Miller EJ; Li J; Leng L; McDonald C; Atsumi T; Bucala R; Young LH
    Nature; 2008 Jan; 451(7178):578-82. PubMed ID: 18235500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart.
    Sambandam N; Lopaschuk GD
    Prog Lipid Res; 2003 May; 42(3):238-56. PubMed ID: 12689619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMPK and metabolic adaptation by the heart to pressure overload.
    Allard MF; Parsons HL; Saeedi R; Wambolt RB; Brownsey R
    Am J Physiol Heart Circ Physiol; 2007 Jan; 292(1):H140-8. PubMed ID: 16920812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of AMP-activated protein kinase in healthy and diseased hearts.
    Dolinsky VW; Dyck JR
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2557-69. PubMed ID: 16844922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bypassing the glucose/fatty acid cycle: AMP-activated protein kinase.
    Carling D; Fryer LG; Woods A; Daniel T; Jarvie SL; Whitrow H
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1157-60. PubMed ID: 14641016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy.
    Tian R; Musi N; D'Agostino J; Hirshman MF; Goodyear LJ
    Circulation; 2001 Oct; 104(14):1664-9. PubMed ID: 11581146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adenosine on myocardial glucose and palmitate metabolism after transient ischemia: role of 5'-AMP-activated protein kinase.
    Jaswal JS; Gandhi M; Finegan BA; Dyck JR; Clanachan AS
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1883-92. PubMed ID: 16648181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase.
    Xing Y; Musi N; Fujii N; Zou L; Luptak I; Hirshman MF; Goodyear LJ; Tian R
    J Biol Chem; 2003 Aug; 278(31):28372-7. PubMed ID: 12766162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress signaling in the heart by AMP-activated protein kinase.
    Russell R
    Curr Hypertens Rep; 2006 Dec; 8(6):446-50. PubMed ID: 17087854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic actions of metformin in the heart can occur by AMPK-independent mechanisms.
    Saeedi R; Parsons HL; Wambolt RB; Paulson K; Sharma V; Dyck JR; Brownsey RW; Allard MF
    Am J Physiol Heart Circ Physiol; 2008 Jun; 294(6):H2497-506. PubMed ID: 18375721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The AMPK gamma1 R70Q mutant regulates multiple metabolic and growth pathways in neonatal cardiac myocytes.
    Folmes KD; Witters LA; Allard MF; Young ME; Dyck JR
    Am J Physiol Heart Circ Physiol; 2007 Dec; 293(6):H3456-64. PubMed ID: 17906100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malonyl CoA control of fatty acid oxidation in the ischemic heart.
    Dyck JR; Lopaschuk GD
    J Mol Cell Cardiol; 2002 Sep; 34(9):1099-109. PubMed ID: 12392882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase: a core signalling pathway in the heart.
    Kim AS; Miller EJ; Young LH
    Acta Physiol (Oxf); 2009 May; 196(1):37-53. PubMed ID: 19239414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy.
    Chan AY; Dyck JR
    Can J Physiol Pharmacol; 2005 Jan; 83(1):24-8. PubMed ID: 15759047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
    Gaidhu MP; Fediuc S; Ceddia RB
    J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.